{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T01:17:54Z","timestamp":1760577474166,"version":"build-2065373602"},"reference-count":48,"publisher":"Elsevier BV","issue":"34","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T00:00:00Z","timestamp":1625616000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["5D43TW010130-04"],"award-info":[{"award-number":["5D43TW010130-04"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"publisher","award":["5D43TW010130-04"],"award-info":[{"award-number":["5D43TW010130-04"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010059","name":"University Of Nigeria Nsukka","doi-asserted-by":"publisher","award":["5D43TW010130-04"],"award-info":[{"award-number":["5D43TW010130-04"]}],"id":[{"id":"10.13039\/501100010059","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.vaccine.2021.06.062","type":"journal-article","created":{"date-parts":[[2021,7,10]],"date-time":"2021-07-10T01:40:43Z","timestamp":1625881243000},"page":"4871-4884","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Carboxymethylated and acetylated xerogel derivatives of Plectranthus esculentus starch protect Newcastle disease vaccines against cold chain failure"],"prefix":"10.1016","volume":"39","author":[{"given":"R.E.","family":"Guktur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.I.","family":"Nep","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Asala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.O","family":"Olorunfemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.C.","family":"Ngwuluka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.A.","family":"Ochekpe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.S.","family":"Sagay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.vaccine.2021.06.062_b0005","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1007\/s00705-019-04288-9","article-title":"Genomic comparison of Newcastle disease viruses isolated in Nigeria between 2002 and 2015 reveals circulation of highly diverse genotypes and spillover into wild birds","volume":"164","author":"Welch","year":"2019","journal-title":"Arch Virol"},{"issue":"3-4","key":"10.1016\/j.vaccine.2021.06.062_b0010","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.vetmic.2009.09.063","article-title":"Emergence of a new genetic lineage of Newcastle disease virus in West and Central Africa-Implications for diagnosis and control","volume":"142","author":"Cattoli","year":"2010","journal-title":"Vet Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2021.06.062_b0015","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1017\/S0266462300014100","article-title":"The Thermostability of Vaccines: Technologies for Improving the Thermostability of the Oral Poliovirus Vaccine","volume":"10","author":"Lemon","year":"1994","journal-title":"Int J Technol Assess Health Care"},{"issue":"5","key":"10.1016\/j.vaccine.2021.06.062_b0020","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.biologicals.2014.05.007","article-title":"Vaccine instability in the cold chain: Mechanisms, analysis and formulation strategies","volume":"42","author":"Kumru","year":"2014","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2021.06.062_b0025","series-title":"Temperature sensitivity of vaccines","first-page":"1","author":"Milstien","year":"2006"},{"issue":"4","key":"10.1016\/j.vaccine.2021.06.062_b0030","doi-asserted-by":"crossref","first-page":"e0118963","DOI":"10.1371\/journal.pone.0118963","article-title":"Effect of chemical stabilizers on the thermostability and infectivity of a representative panel of freeze dried viruses","volume":"10","author":"Pastorino","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2021.06.062_b0035","first-page":"1","author":"Flood","year":"2016","journal-title":"Development of Freeze Dried heat stable influenza vaccine"},{"year":"2004","series-title":"Desired characteristics of a lyophilized product Understanding Lyophilization Formulation Development","author":"Bedu-Addo","key":"10.1016\/j.vaccine.2021.06.062_b0040"},{"issue":"6","key":"10.1016\/j.vaccine.2021.06.062_b0045","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1007\/s11095-008-9559-6","article-title":"Development of stable influenza vaccine powder formulations: Challenges and possibilities","volume":"25","author":"Amorij","year":"2008","journal-title":"Pharm Res"},{"issue":"13","key":"10.1016\/j.vaccine.2021.06.062_b0050","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.addr.2011.06.011","article-title":"Interactions of formulation excipients with proteins in solution and in the dried state","volume":"63","author":"Ohtake","year":"2011","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2021.06.062_b0055","doi-asserted-by":"crossref","first-page":"231","DOI":"10.4149\/av_2017_301","article-title":"Viral vaccine stabilizers: Status and trends","volume":"61","author":"Cardoso","year":"2017","journal-title":"Acta Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2021.06.062_b0060","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.ejpb.2013.03.033","article-title":"The effect of freeze-drying parameters and formulation composition on IgG stability during drying","volume":"85","author":"Heljo","year":"2013","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"10.1016\/j.vaccine.2021.06.062_b0065","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.aoas.2012.03.008","article-title":"Physico-chemical and rheological properties of modified corn starches and its effect on noodle quality","volume":"57","author":"Yousif","year":"2012","journal-title":"Ann Agric Sci"},{"issue":"3","key":"10.1016\/j.vaccine.2021.06.062_b0070","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.foodchem.2009.03.019","article-title":"Effects of cross-linking and acetylation on oat starch properties","volume":"116","author":"Mirmoghtadaie","year":"2009","journal-title":"Food Chem"},{"key":"10.1016\/j.vaccine.2021.06.062_b0075","article-title":"Chemical Modifications and their effects on Binding\/Disintegrating properties of Plectranthus esculentus starch in Chloroquine Phosphate tablets","volume":"3","author":"Ochekpe","year":"2013","journal-title":"J PharmTech Res Am J PharmTech Res Am J PharmTech Res"},{"issue":"12","key":"10.1016\/j.vaccine.2021.06.062_b0080","doi-asserted-by":"crossref","first-page":"8364","DOI":"10.1007\/s13197-015-1891-3","article-title":"Effect of chemical modifications on thermal, rheological and morphological properties of yellow sorghum starch","volume":"52","author":"Olayinka","year":"2015","journal-title":"J Food Sci Technol"},{"key":"10.1016\/j.vaccine.2021.06.062_b0085","doi-asserted-by":"crossref","unstructured":"Nirmala L, Nayak V, And SKD, Deecaraman. Immunization strategies and enhanced immunity of typhoid vaccine using potato starch polymer as an adjuvant. Indian J Sci Technol 2011;4:404\u20139.","DOI":"10.17485\/ijst\/2011\/v4i4.19"},{"key":"10.1016\/j.vaccine.2021.06.062_b0090","unstructured":"Tian W, McLaughlin R. Oral Vaccine Fast-dissolving Dosage Form Using Starch. US 9,956,169 B2, 2018."},{"key":"10.1016\/j.vaccine.2021.06.062_b0095","unstructured":"Qiao Z, O\u2019Connell K. US9839613 Room temp stable vaccine.pdf. US 9,839,613 B2, 2017."},{"key":"10.1016\/j.vaccine.2021.06.062_b0100","first-page":"906","article-title":"Comparative Evaluation of the Binding\/Disintegrating Properties of Plectranthus Esculentus Starch","volume":"2","author":"Kemas","year":"2013","journal-title":"World J Pharm Pharm Sci"},{"issue":"3","key":"10.1016\/j.vaccine.2021.06.062_b0105","doi-asserted-by":"crossref","first-page":"249","DOI":"10.17306\/J.AFS.2014.3.3","article-title":"Use of indigenous technology for the production of high quality cassava flour with similar food qualities as wheat flour","volume":"13","author":"Eleazu","year":"2014","journal-title":"Acta Sci Pol Technol Aliment"},{"key":"10.1016\/j.vaccine.2021.06.062_b0110","first-page":"472","article-title":"Evaluation of Livingstones Potato\/Rizga (Plectranthus esculentus N. Br.) and Hausa Potato (Solenostemon rotundifolius Poir) as energy sources for broiler Chicken","volume":"5","author":"Ojewola","year":"2006","journal-title":"J Anim Vet Adv"},{"key":"10.1016\/j.vaccine.2021.06.062_b0115","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.foodhyd.2016.02.037","article-title":"Rheological and structural properties of modified starches from the young shoots of Borassus aethiopium","volume":"60","author":"Nep","year":"2016","journal-title":"Food Hydrocoll"},{"key":"10.1016\/j.vaccine.2021.06.062_b0120","doi-asserted-by":"crossref","unstructured":"Kemas CU, Ngwuluka NC, Ochekpe NA, Nep EI. Starch-based xerogels: Effect of acetylation on Physicochemical and rheological properties. vol. 98. Elsevier B.V.; 2017. https:\/\/doi.org\/10.1016\/j.ijbiomac.2017.01.101.","DOI":"10.1016\/j.ijbiomac.2017.01.101"},{"key":"10.1016\/j.vaccine.2021.06.062_b0125","article-title":"Physicochemical, rheological and functional properties of modified starches from the tubers of Plectranthus esculentus Pleactranthus esculentus starch","volume":"4","author":"Kemas","year":"2020","journal-title":"Br J Pharm"},{"key":"10.1016\/j.vaccine.2021.06.062_b0130","unstructured":"Miller PJ, Afonso CL, Grund C, Koch G, Peeters B, Selleck PW, et al. Newcastle disease (Infection with Newcastle Disease Virus). In Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. OIE (Office Int. des \u00e9pizooties) Man. Diagnostic Tests Vaccines Terr. Anim. (Terrestrial Manual) 2019. 2019th ed., OIE; 2019, p. 964\u201383."},{"key":"10.1016\/j.vaccine.2021.06.062_b0135","doi-asserted-by":"crossref","unstructured":"Rezatofighi SE, Seydabadi A, Seyyed Nejad SM. Evaluating the Efficacy of Achillea millefolium and Thymus vulgaris Extracts Against Newcastle Disease Virus in Ovo. Jundishapur J Microbiol 2014;7:1\u20135. https:\/\/doi.org\/10.5812\/jjm.9016.","DOI":"10.5812\/jjm.9016"},{"key":"10.1016\/j.vaccine.2021.06.062_b0140","article-title":"Controlling Newcastle disease in village chickens","author":"Young","year":"2002","journal-title":"A Laboratory Manual."},{"key":"10.1016\/j.vaccine.2021.06.062_b0145","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty per cent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2021.06.062_b0150","first-page":"501","article-title":"Carboxymethyl starch with high degree of substitution: Synthesis, properties and application","volume":"58","author":"Spychaj","year":"2013","journal-title":"Polimery\/Polymers"},{"issue":"4","key":"10.1016\/j.vaccine.2021.06.062_b0155","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3390\/pharmaceutics12040303","article-title":"The influence of moisture content and temperature on the long-term storage stability of freeze-dried high concentration immunoglobulin G (IgG)","volume":"12","author":"Duralliu","year":"2020","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.vaccine.2021.06.062_b0160","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.3382\/ps.2009-00620","article-title":"Development of a stabilizer for lyophilization of an attenuated duck viral hepatitis vaccine","volume":"89","author":"Kang","year":"2010","journal-title":"Poult Sci"},{"key":"10.1016\/j.vaccine.2021.06.062_b0165","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/1520-6017(200103)90:3<310::AID-JPS6>3.0.CO;2-R","article-title":"A specific molar ratio of stabilizer to protein is required for storage stability of a lyophilized monoclonal antibody","volume":"90","author":"Cleland","year":"2001","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.vaccine.2021.06.062_b0170","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.vetmic.2018.11.013","article-title":"Hemagglutinin-Neuraminidase and fusion genes are determinants of NDV thermostability","volume":"228","author":"Liu","year":"2019","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2021.06.062_b0175","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.vetmic.2016.12.019","article-title":"Newcastle disease vaccines\u2014A solved problem or a continuous challenge?","volume":"206","author":"Dimitrov","year":"2017","journal-title":"Vet Microbiol"},{"issue":"10","key":"10.1016\/j.vaccine.2021.06.062_b0180","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1080\/21645515.2017.1356952","article-title":"Developments in the formulation and delivery of spray dried vaccines","volume":"13","author":"Kanojia","year":"2017","journal-title":"Hum Vaccin Immunother"},{"issue":"4","key":"10.1016\/j.vaccine.2021.06.062_b0185","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1007\/s00253-019-10280-9","article-title":"Engineering viable foot-and-mouth disease viruses with increased acid stability facilitate the development of improved vaccines","volume":"104","author":"Yuan","year":"2020","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.vaccine.2021.06.062_b0190","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.bpj.2014.02.018","article-title":"PH-ontrolled two-step uncoating of influenza virus","volume":"106","author":"Li","year":"2014","journal-title":"Biophys J"},{"key":"10.1016\/j.vaccine.2021.06.062_b0195","first-page":"87","article-title":"Thermostability of Reconstituted Newcastle Disease Virus Strains at 36 0C Temperature","volume":"5","author":"Nssien","year":"2002","journal-title":"African J Biomed Res"},{"issue":"5","key":"10.1016\/j.vaccine.2021.06.062_b0200","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1586\/erv.09.20","article-title":"Opportunities and challenges of developing thermostable vaccines","volume":"8","author":"Chen","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2021.06.062_b0205","first-page":"4168","article-title":"Effects of temperature on stability of haemagglutination titers of stabilized Newcastle disease vaccines","volume":"2","author":"Guktur","year":"2013","journal-title":"World J F Pharm Pharmaeutical Sci"},{"key":"10.1016\/j.vaccine.2021.06.062_b0210","doi-asserted-by":"crossref","unstructured":"Abdi RD, Tadesse KA, Merera O, Asfaw Y, Gelaye E, Yami M, et al. Erratum to: Serological response and protection level evaluation in chickens exposed to grains coated with I2 Newcastle disease virus for effective oral vaccination of village chickens [BMC Vet Res, 12, (2016((150)] Doi: 10.1186\/s12917-016-0785-6. BMC Vet Res 2016;12:12917. https:\/\/doi.org\/10.1186\/s12917-016-0909-z.","DOI":"10.1186\/s12917-016-0909-z"},{"key":"10.1016\/j.vaccine.2021.06.062_b0215","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12917-018-1355-x","article-title":"Evaluation of spray and oral delivery of Newcastle disease I2 vaccine in chicken reared by smallholder farmers in central Ethiopia","volume":"14","author":"Mebrahtu","year":"2018","journal-title":"BMC Vet Res"},{"key":"10.1016\/j.vaccine.2021.06.062_b0220","doi-asserted-by":"crossref","unstructured":"Zoth S., G\u00f3mez E, Carrillo E, Berinstein A. Locally produced mucosal IgG in chickens immunized with conventional vaccines for Newcastle disease virus. Brazilian J Med Biol Res 2008;41:318\u201323. https:\/\/doi.org\/10.1590\/S0100-879X2008000400010.","DOI":"10.1590\/S0100-879X2008000400010"},{"key":"10.1016\/j.vaccine.2021.06.062_b0225","first-page":"411","article-title":"Humoral Immune Response to Newcastle Disease Vaccine (LaSota Strain)","volume":"5","author":"Shuaib","year":"2006","journal-title":"Broilers"},{"issue":"10","key":"10.1016\/j.vaccine.2021.06.062_b0230","doi-asserted-by":"crossref","first-page":"999","DOI":"10.3923\/ijps.2009.999.1002","article-title":"The Effect of Storage Conditions on the Potency of Newcastle Disease Vaccine La Sota","volume":"8","author":"Okwor","year":"2009","journal-title":"Int J Poult Sci"},{"key":"10.1016\/j.vaccine.2021.06.062_b0235","doi-asserted-by":"crossref","unstructured":"Bello MB, Mahamud SNA, Yusoff K, Ideris A, Hair-Bejo M, Peeters BPH, et al. Development of an effective and stable genotype-matched live attenuated newcastle disease virus vaccine based on a novel naturally recombinant malaysian isolate using reverse genetics. Vaccines 2020;8. https:\/\/doi.org\/10.3390\/vaccines8020270.","DOI":"10.3390\/vaccines8020270"},{"issue":"12","key":"10.1016\/j.vaccine.2021.06.062_b0240","doi-asserted-by":"crossref","first-page":"e53314","DOI":"10.1371\/journal.pone.0053314","article-title":"Preparation and Efficacy of a Live Newcastle Disease Virus Vaccine Encapsulated in Chitosan Nanoparticles","volume":"7","author":"Zhao","year":"2012","journal-title":"PLoS ONE"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21008124?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21008124?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:59:39Z","timestamp":1759402779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21008124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":48,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0264410X21008124"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.06.062","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Carboxymethylated and acetylated xerogel derivatives of Plectranthus esculentus starch protect Newcastle disease vaccines against cold chain failure","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.06.062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}